Sep 22, 2026 8 0
Uploaded by Sarah
Favorite
Share
More Options
15
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion–Positive Non–Small Cell Lung Cancer_Page 1

Open in WPS to view all 15 pages